Evidence map›Paper›PMID 35086546›Full record

ArticleThe international journal of behavioral nutrition and physical activity2022

Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain.

Mario Delgado-Velandia, Vannina Gonzalez-Marrachelli, Arce Domingo-Relloso, Marta Galvez-Fernandez, Maria Grau-Perez, Pablo Olmedo, Iñaki Galan, Fernando Rodriguez-Artalejo, Nuria Amigo, Laisa Briongos-Figuero and 5 more

Open access · goldAbstract read
In one paragraph

Article in The international journal of behavioral nutrition and physical activity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Combining Ability ofCurrent issues in molecular biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Metabolomic Profile Alterations Associated with theCurrent developments in nutrition · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Mario Delgado-VelandiaDepartment of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
Vannina Gonzalez-MarrachelliDepartment of Physiology, School of Medicine, University of Valencia, Valencia, Spain.
Arce Domingo-RellosoIntegrative Epidemiology Group, Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Carlos III Health Institutes, Madrid, Spain.
Marta Galvez-FernandezDepartment of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
Maria Grau-PerezDepartment of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
Pablo OlmedoInstitute for Biomedical Research Hospital Clinic de Valencia INCLIVA, Valencia, Spain.
Iñaki GalanDepartment of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
Fernando Rodriguez-ArtalejoDepartment of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
Nuria AmigoBiosfer Teslab, Av. Universitat, 1 43204, Reus, Spain.
Laisa Briongos-FigueroDepartment of Internal Medicine, University Hospital Rio Hortega, Valladolid, Spain.
Josep RedonInstitute for Biomedical Research Hospital Clinic de Valencia INCLIVA, Valencia, Spain.
Juan Carlos Martin-EscuderoDepartment of Internal Medicine, University Hospital Rio Hortega, Valladolid, Spain.
Daniel Monleon-SalvadoDepartment of Physiology, School of Medicine, University of Valencia, Valencia, Spain. daniel.monleon@uv.es.
Maria Tellez-Plaza *Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain. m.tellez@isciii.es.ORCID 0000-0002-3850-1228
Mercedes Sotos-Prieto *Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autonoma de Madrid; Instituto de Investigacion Sanitaria Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
Hospital Universitario La Paz · ESUniversitat de València · ESHospital Universitario Río Hortega · ESMadrid Institute for Advanced Studies · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESINCLIVA Health Research Institute · ESUniversidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe contribution of metabolomic factors to the association of healthy lifestyle with type 2 diabetes risk is unknown. We assessed the association of a composite measure of lifestyle with plasma metabolite profiles and incident type 2 diabetes, and whether relevant metabolites can explain the prospective association between healthy lifestyle and incident type 2 diabetes.

methodsA Healthy Lifestyle Score (HLS) (5-point scale including diet, physical activity, smoking status, alcohol consumption and BMI) was estimated in 1016 Hortega Study participants, who had targeted plasma metabolomic determinations at baseline examination in 2001-2003, and were followed-up to 2015 to ascertain incident type 2 diabetes.

resultsThe HLS was cross-sectionally associated with 32 (out of 49) plasma metabolites (2.5% false discovery rate). In the subset of 830 participants without prevalent type 2 diabetes, the rate ratio (RR) and rate difference (RD) of incident type 2 diabetes (n cases = 51) per one-point increase in HLS was, respectively, 0.69 (95% CI, 0.51, 0.93), and - 8.23 (95% CI, - 16.34, - 0.13)/10,000 person-years. In single-metabolite models, most of the HLS-related metabolites were prospectively associated with incident type 2 diabetes. In probit Bayesian Kernel Machine Regression, these prospective associations were mostly driven by medium HDL particle concentration and phenylpropionate, followed by small LDL particle concentration, which jointly accounted for ~ 50% of the HLS-related decrease in incident type 2 diabetes.

conclusionsThe HLS showed a strong inverse association with incident type 2 diabetes, which was largely explained by plasma metabolites measured years before the clinical diagnosis.

Indexed as

Diabetes Mellitus, Type 2Bayes TheoremHealthy LifestyleHumansMetabolomicsRisk FactorsSpainCohort studyHealthy lifestyleMetabolomicsSpanish populationType 2 diabetes

Identifiers

PMID35086546
PMCPMC8793258
OpenAlexW4210633572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.